Pentosan polysulfate sodium, otherwise known as Elmiron, was approved on September 26, 1996, by the FDA to treat interstitial cystitis, a painful bladder disorder. Elmiron was recently linked to vision-related injuries, including eye damage.
Elmiron’s Side Effects Studies
Emory Eye Center conducted two different studies in May 2018 and April 2019. Both showed a direct correlation between Elmiron and pigmentary maculopathy and macular degeneration, two very severe eye disorders. Symptoms associated with macular degeneration include blindness, prolonged dark adaptation, spotty, dimmed, or blurred vision, and central vision loss.
A study conducted by Kaiser Permanente reviewed medical records from 4.3 million Elmiron patients, according to a recent report from Science Direct. The study showed that as the dosage and quantity of Elmiron increased, the dose-response relationship increased (the amount of eye damage the patients suffered).
Elmiron’s Warning Labels
Most Elmiron lawsuits filed against Janssen Pharmaceuticals, the manufacturing company, and other drug companies, were due to their failure to warn patients and doctors adequately about the potential vision issues associated with the medication.
Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson, has changed their labels on their bladder pain drug in the background of increasing lawsuits. Under the “Warnings” section, the United States had previously listed no risks. The new Elmiron warning label now includes “Retinal Pigmentary Changes.” The label change was recently approved by the FDA on June 16. Canadian authorities required these warnings to be listed on Elmiron’s label back in October 2019, and a warning label was demanded by the European Medicines Agency as far back as June 2019.
The updated Elmiron warning label now specifies that the medication can change retinal pigments, causing sensitivity to low light, reading problems, and blurred vision. It also recommends that people have their eyesight regularly tested while taking the drug.
This new warning label will help potential users of Elmiron make more informed decisions, but it’s too late for those who have already suffered eye damage as a result of taking it. Even if a patient discontinues Elmiron, their eyesight can continue to worsen, according to the new Elmiron warning label. These changes may also be irreversible.
Elmiron Eye Disease Lawsuit
One Elmiron lawsuit claimed that the plaintiff had developed maculopathy, a degenerative retinal disease while taking the drug. The plaintiff started taking Elmiron in 2012 to treat interstitial cystitis. The plaintiff’s vision deteriorated rapidly six years later, and so they filed a lawsuit against Johnson & Johnson after they were diagnosed with permanent retinal eye injury to both eyes.
The lawsuit claims that the medical community was unaware of the risks associated with this defective, dangerous medication when it was marketed, designed, and distributed. The complaint also indicates that Janssen Pharmaceuticals failed to disclose the hazardous risks between Elmiron use and significant visual damage, related to pigmentary maculopathy, and withheld material adverse events.
The attorney for the plaintiff said that the prescribing information and the label that accompanied the drug contained no warnings. There was no mention of maculopathy or permanent vision loss in the patient leaflet, prescription guide, or on Elmiron’s website during the time the plaintiff began taking the medication.
Neither Janssen Pharmaceuticals nor their parent company, Johnson & Johnson, have issued any official statements about the lawsuit, but the company is expected to deny any wrongdoing.
Qualified Elmiron Plaintiffs
Broughton Partners has a team of professionals who will work effectively and quickly to get you the potential clients you need. We’ll provide you with qualified retainers to suit your exact specifications, and send them to you with all of the histories and documents necessary for their cases. We value a law firm’s time and understand the legal industry, which is why we are committed to delivering qualified Elmiron plaintiffs instead of just leads.
We Offer More Than Just Elmiron Campaigns
The services we provide for attorneys include taking on additional clients without worrying whether or not they are qualified. There are specific criteria that a claimant must meet to be fully vetted by our company, unlike lead generation agencies. If a claimant doesn’t meet these criteria, we won’t send them to you.
We can do this through our digital marketing services, our exclusive analytics and software, and our 24-hour intake center.
These tactics to find qualified clients are performed by a highly-trained group of intake agents who specialize in these departments.
We Review All Potential Elmiron Plaintiffs For Quality
As we search for Elimiron victims, we keep in mind your company’s requirements and specifications. If we feel that a claimant may not be a good fit for your firm, we won’t waste our time and valuable efforts on them. Our reliable, eligible claimants pass a stringent qualification process that includes detailed interviews, a thorough examination of essential documents, and a pre-analysis of the details surrounding your case.
Finding reliable leads can be difficult, especially leads that are not only high-quality but case-ready as well. We’ll help you find qualified retainers for your law firm so you can spend more time focusing on the cases you have in front of you.
Finding Elmiron Plaintiffs
We have a professional, in-house marketing team that will target and connect with victims who need legal advice regarding their case. Once potential plaintiffs have shown interest, or after they call, we will track the case leads online with our exclusive case-acquisition solution. For the best results, our system is continuously optimized to ensure that law firms are receiving only qualified retainers.
Our in-house call center is staffed 24-hours a day, seven days a week. We are always on duty every day. We also offer year-round service from highly-trained, multilingual professionals who can navigate through possible leads in order to find the qualified retainers you need, which allows our team to serve cities all across the United States. All of our intake associates know how to handle every intake session with the highest level of compassion and professionalism. Our in-house call center will examine potential clients via a qualified process based on your law firm’s criteria, as well as through a set of customized questions.
Once a qualified lawsuit lead has been found, our team will gather the appropriate case documents your law firm will need so they can begin working on the case immediately.
Contact Us To Help More Victims of Elmiron
For a free consultation, call (800) 949-8904 or fill out an online contact form.